Literature DB >> 5452388

[Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

H Held, B Kaminski, H F von Oldershausen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5452388     DOI： 10.1007/bf01212070

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  28 in total

1.  SEVERE HYPOGLYCEMIA IN ELDERLY PATIENTS RECEIVING THERAPEUTIC DOSES OF TOLBUTAMIDE.

Authors:  P GARDNER; C J GOODNER; J T DOWLING
Journal:  JAMA       Date:  1963-12-14       Impact factor: 56.272

2.  SEVERE HYPOGLYCEMIA: RESULT OF RENAL RETENTION OF CHLORPROPAMIDE.

Authors:  E L ROTHFELD; A H CREWS; S RIBOT; A BERNSTEIN
Journal:  Arch Intern Med       Date:  1965-04

3.  HYPOGLYCEMIA IN TOLBUTAMIDE-TREATED DIABETES; REPORT OF TWO CASES WITH MEASUREMENT OF SERUM INSULIN.

Authors:  J S SOELDNER; J STEINKE
Journal:  JAMA       Date:  1965-08-02       Impact factor: 56.272

4.  [Potentiation of tolbutamide by phenylbutazone].

Authors:  R GULBRANDSEN
Journal:  Tidsskr Nor Laegeforen       Date:  1959-10-01

5.  Tolbutamide-induced hypoglycemia. Report of an unusual case.

Authors:  N KREEGER
Journal:  N Engl J Med       Date:  1962-04-19       Impact factor: 91.245

6.  [The retarding effect of dioxydiphenylbutylpyrazolidin (butazolidine) on different drugs, especially analgesics].

Authors:  G WILHELMI
Journal:  Helv Physiol Pharmacol Acta       Date:  1952-09

7.  Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects.

Authors:  H M Solomon; J J Schrogie
Journal:  Metabolism       Date:  1967-11       Impact factor: 8.694

8.  [On 2-benzolsulfonylamino-5 (beta-methoxyethoxy) pyrimidine (Glycodiazin). VII. On the mechanism of demethylation of Glycodiazin].

Authors:  E Gerhards
Journal:  Arzneimittelforschung       Date:  1968-06

9.  [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].

Authors:  E Schulz; W Brinkmann
Journal:  Dtsch Med Wochenschr       Date:  1968-03-15       Impact factor: 0.628

10.  [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].

Authors:  E GERHARDS; H GIBIAN; K H KOLB
Journal:  Arzneimittelforschung       Date:  1964-05
View more
  1 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.